Innovation and the Opioid Crisis
A $40B+ industry in the US alone. Big Fines for Big Pharma, emerging policy and new “Addiction Tech” on a mission to change the paradigm for the treatment of pain.
5 May 2022
The treatment of drug, alcohol and other substance addictions in the US alone is estimated to be a $40B+ industry that is being targeted by a range of tech innovators looking to disrupt a sector struggling to cope with the spiraling opioid crisis.
Digital health firms are adopting a variety of business models to shake up this relatively unreformed market, including; telehealth, remote prescribing, digital cognitive behavior therapy, peer support networks and audiovisual sensory treatments. In the 12 months to April 2021 deaths from drug overdoses passed 100k in the US, a 28.5% increase on the same period the year before.
Customers can read the full analyst note on-platform. Not a customer yet? Request a demo of HolonIQ’s market intelligence platform.
Where is this data coming from?
Related Research
Healthcare Megarounds: 2022 activity dominated by Biotech
21 May 2022.66 healthcare funding rounds in excess of $100M, totalling $11.7B in ‘megarounds’ despite a rapidly cooling market
2021 North America HealthTech 200. Where are they now?
20 May 2022.How are North America Top 200 HealthTech Startups of 2021 performing and where are they now?
4 webinars to explore disruptive innovation in digital health
19 May 2022.Join HolonIQ’s Health Intelligence Unit in a series of webinars focused on the fast-moving world of digital health.
The Complete List of Global Impact Unicorns
8 May 2022.The Complete List of Global Impact Unicorns
Sign up to the Newsletter
Sign up to our free weekly newsletter to stay a step ahead on the global impact economy, climate tech, education and digital health trends, innovation and investment and the future of inclusivity and sustainability.
